• About
    • Team
    • Contact
  • Ophthalmics
  • Investors
    • AGM Notices
    • Financials
    • Research & Development
  • News


Home
/
Investors
/
Financials & Notices

Year Ended 2024

Genix FS Q1 2024 FINAL

Genix MD&A Q1 2024 FINAL

Genix FS Q2 2024 FINAL

Genix MD&A Q2 2024 FINAL

Year Ended 2023

Genix FS Q1 2023 FINAL

Genix MD&A Q1 2023 FINAL

Genix FS Q2 2023 FINAL

Genix MD&A Q2 2023 FINAL

Genix FS Q3 2023 FINAL

Genix MD&A Q3 2023 FINAL

Genix FS Q4 2023 Final

Genix MD&A Q4 2023 FINAL

Years Ended 2022

Genix – FS Q4 2022 Final

Genix – MD&A Q4 2022 FINAL

Genix FS Q3 2022 FINAL

Genix MD&A Q3 2022 FINAL

Genix FS Q2 2022 FINAL

Genix MD&A Q2 2022 FINAL

Genix FS Q1 2022 FINAL

Genix MD&A Q1 2022 FINAL

Years Ended 2021

Financial Statements October 31, 2021

For all other filings please follow the link to SEDAR

Suite 300, 1055 West Hastings St, Vancouver, BC, V6E 2E9
604.609.6198
info@genixpharm.com

LINKS

  • Ophthalmics
  • Investors
  • News

OUR COMPANY

  • About
  • Investors
  • Contact
  • Disclaimers
  • Terms of service

OUR NEWSLETTER

Subscribe to the mailing list to receive updates on new arrivals, special offers and other information


© 2022 Created by Genix Pharmaceuticals